Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COVID-19-associated coagulopathy and antithrombotic agents—lessons after 1 year
Jenneke Leentjens, Thijs F. van Haaps, Pieter Wessels, et al.
The Lancet Haematology (2021) Vol. 8, Iss. 7, pp. e524-e533
Open Access | Times Cited: 219

Showing 26-50 of 219 citing articles:

COVID-19 and Cardiac Arrhythmias: a Contemporary Review
Sandeep Saha, Andrea Russo, Mina K. Chung, et al.
Current Treatment Options in Cardiovascular Medicine (2022) Vol. 24, Iss. 6, pp. 87-107
Open Access | Times Cited: 32
Discordance and bleeding in critically ill patients with COVID-19 receiving unfractionated heparin: a comparison between aPTT and anti-factor Xa activity level monitoring
Merijn C. Reuland, Thijs F. van Haaps, Pieter O.L.P. Broeren, et al.
Thrombosis Update (2025), pp. 100202-100202
Open Access
A Retrospective Multicenter Study of Arterial Thromboembolic Events in Hospitalized COVID-19 Patients: Incidence and Imaging Characteristics
David Schinz, Marcel Ploch, Andreas Saleh, et al.
Clinical Neuroradiology (2025)
Open Access
Altered platelet and coagulation function in moderate-to-severe COVID-19
Rustem I. Litvinov, Natalia G. Evtugina, Alina D. Peshkova, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 39
Role of SARS-CoV-2 -induced cytokines and growth factors in coagulopathy and thromboembolism
Firdos Ahmad, Meganathan Kannan, Abdul W. Ansari
Cytokine & Growth Factor Reviews (2021) Vol. 63, pp. 58-68
Open Access | Times Cited: 35
Learning through a Pandemic: The Current State of Knowledge on COVID-19 and Cancer
Arielle Elkrief, Julie Wu, Chinmay Jani, et al.
Cancer Discovery (2021) Vol. 12, Iss. 2, pp. 303-330
Open Access | Times Cited: 33
Cytokine Elevation in Severe COVID-19 From Longitudinal Proteomics Analysis: Comparison With Sepsis
Takeshi Ebihara, Hisatake Matsumoto, Tsunehiro Matsubara, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 26
Pathophysiology of COVID-19: Critical Role of Hemostasis
Sonia Aparecida de Andrade, Daniel Alexandre De Souza, Amarylis Lins Torres, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 26
Immune-Guided Therapy of COVID-19
Gianfranco Ferraccioli, Elisa Gremese, Delia Goletti, et al.
Cancer Immunology Research (2022) Vol. 10, Iss. 4, pp. 384-402
Open Access | Times Cited: 25
Intestinal Damage in COVID-19: SARS-CoV-2 Infection and Intestinal Thrombosis
Xiaoming Wu, Haijiao Jing, Chengyue Wang, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 25
The host response in different aetiologies of community-acquired pneumonia
Alex R. Schuurman, Tom D. Y. Reijnders, Tjitske S. R. van Engelen, et al.
EBioMedicine (2022) Vol. 81, pp. 104082-104082
Open Access | Times Cited: 25
Ocular and Systemic Complications of COVID-19: Impact on Patients and Healthcare
Ella H. Leung, Jason Fan, Harry W. Flynn, et al.
Clinical ophthalmology (2022) Vol. Volume 16, pp. 1-13
Open Access | Times Cited: 24
D‐dimer testing in clinical practice in the era of COVID‐19
Claire Auditeau, Lina Khider, Benjamin Planquette, et al.
Research and Practice in Thrombosis and Haemostasis (2022) Vol. 6, Iss. 4, pp. e12730-e12730
Open Access | Times Cited: 22
Colchicine and the combination of rivaroxaban and aspirin in patients hospitalised with COVID-19 (ACT): an open-label, factorial, randomised, controlled trial
John W. Eikelboom, Sanjit S. Jolly, Emilie P. Belley‐Côté, et al.
The Lancet Respiratory Medicine (2022) Vol. 10, Iss. 12, pp. 1169-1177
Open Access | Times Cited: 22
COVID-19 Vaccine-Associated Immune Thrombosis and Thrombocytopenia (VITT): Diagnostic Discrepancies and Global Implications
Ali Zidan, Abdelrahman Noureldin, Shreya Anil Kumar, et al.
Seminars in Thrombosis and Hemostasis (2023) Vol. 49, Iss. 01, pp. 009-014
Open Access | Times Cited: 13
Thrombotic complications in children with Coronavirus disease 2019 and Multisystem Inflammatory Syndrome of Childhood
Riten Kumar, Michael J. Rivkin, Leslie Raffini
Journal of Thrombosis and Haemostasis (2023) Vol. 21, Iss. 9, pp. 2313-2326
Open Access | Times Cited: 13
Alterations in platelet proteome signature and impaired platelet integrin αIIbβ3 activation in patients with COVID-19
Lucy J. Goudswaard, Christopher Williams, Jawad Khalil, et al.
Journal of Thrombosis and Haemostasis (2023) Vol. 21, Iss. 5, pp. 1307-1321
Open Access | Times Cited: 12
The Platelet Lipidome Is Altered in Patients with COVID-19 and Correlates with Platelet Reactivity
Alex R. Schuurman, Valentine Léopold, Е. В. Переверзева, et al.
Thrombosis and Haemostasis (2022) Vol. 122, Iss. 10, pp. 1683-1692
Open Access | Times Cited: 21
Assessment and Management of Long COVID
Rafael A. Rivas-Vazquez, Gustavo Rey, Alan Quintana, et al.
Journal of Health Service Psychology (2022) Vol. 48, Iss. 1, pp. 21-30
Open Access | Times Cited: 19
Longitudinal multiparametric characterization of platelet dysfunction in COVID-19: Effects of disease severity, anticoagulation therapy and inflammatory status
A. A. Martyanov, Anna E. Boldova, M. G. Stepanyan, et al.
Thrombosis Research (2022) Vol. 211, pp. 27-37
Open Access | Times Cited: 18
COVID-19: a multi-organ perspective
F Guarienti, João Ismael Budelon Gonçalves, Júlia Budelon Gonçalves, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 3
COVID-19: Lung-Centric Immunothrombosis
Peter R. Kvietys, Hana Fakhoury, Sana Kadan, et al.
Frontiers in Cellular and Infection Microbiology (2021) Vol. 11
Open Access | Times Cited: 26
Coagulopathy and COVID-19
Ferdinando Luca Lorini, Maria Di Matteo, Paolo Gritti, et al.
European Heart Journal Supplements (2021) Vol. 23, Iss. Supplement_E, pp. E95-E98
Open Access | Times Cited: 26
Severe Dysbiosis and Specific Haemophilus and Neisseria Signatures as Hallmarks of the Oropharyngeal Microbiome in Critically Ill Coronavirus Disease 2019 (COVID-19) Patients
Juliana de Castilhos, Eli Zamir, Theresa Hippchen, et al.
Clinical Infectious Diseases (2021) Vol. 75, Iss. 1, pp. e1063-e1071
Open Access | Times Cited: 26
Overlapping but Disparate Inflammatory and Immunosuppressive Responses to SARS-CoV-2 and Bacterial Sepsis: An Immunological Time Course Analysis
Tyler J. Loftus, Ricardo Ungaro, Marvin L. Dirain, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 25

Scroll to top